100.00% -0.60

Aslan Pharmaceuticals Ltd Adr (ASLN)

Aslan Pharmaceuticals Ltd Adr Aktie (ASLN) Neueste Nachrichten

Aslan Pharmaceuticals Ltd Adr (ASLN)

Aslan Pharmaceuticals Ltd Adr Aktie (ASLN) Neueste Nachrichten

United States shares mixed at close of trade; Dow Jones Industrial Average up 0.59% - Investing.com India

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59% - Investing.com

Is ASLAN Pharmaceuticals Ltd ADR (NASDAQ: ASLN) Doomed To Fail? - Stocks Register

Crude Oil Rises 2%; Five Below Shares Plunge - Benzinga

ASLAN Pharmaceuticals Ltd ADR (ASLN) is looking forward to a strong quarter - SETE News

The Future of ASLAN Pharmaceuticals Ltd ADR: Analyzing ASLN - The InvestChronicle

Closing Figures: ASLAN Pharmaceuticals Ltd ADR (ASLN)’s Negative Finish at 1.38, Down -45.88 - The Dwinnex

United States shares higher at close of trade; Dow Jones Industrial Average up 0.53% - Investing.com India

ASLAN Pharmaceuticals faces delisting from Nasdaq - Investing.com

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.53% - Investing.com

Short Interest in ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Declines By 85.8% - American Banking and Market News

Short Interest in ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Declines By 85.8% - Defense World

Market Insights: ASLAN Pharmaceuticals Ltd ADR (ASLN)'s Notable Gain of 0.98, Closing at 2.27 – DWinneX - The Dwinnex

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Short Interest Down 9.2% in June - Defense World

ASLAN Pharmaceuticals to Host Third Webinar in A⁴ KOL Series: 'Dialogues With International Thought Leaders in ... - Barchart

ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly - Yahoo Canada Shine On

ASLAN Pharmaceuticals Stock Scheduled to Reverse Split on Wednesday, July 3rd (NASDAQ:ASLN) - Defense World

Financial Metrics Exploration: Understanding ASLAN Pharmaceuticals Ltd ADR (ASLN) Through Ratios – DWinneX - The Dwinnex

ASLAN Pharmaceuticals Ltd ADR (ASLN) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change - GlobeNewswire Inc.

Aslan Pharmaceuticals to Change Ratio to 1 ADS to 200 Shares - MarketWatch

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.12% - MSN

New Strong Sell Stocks for June 8th - Yahoo Lifestyle Australia

All You Need to Know About ASLAN Pharmaceuticals (ASLN) Rating Upgrade to Buy - Zacks Investment Research

Here's Why ASLAN Pharmaceuticals (ASLN) Could be Great Choice for a Bottom Fisher - Zacks Investment Research

Post-Trade Analysis: ASLAN Pharmaceuticals Ltd ADR (ASLN) Slides -3.15, Closing at 0.43 – DWinneX - The Dwinnex

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Short Interest Update - Defense World

ProQR (PRQR) Rises on Expanding RNA-Editing Deal With Eli Lilly - Yahoo Movies Canada

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American ... - Investing.com India

ASLAN Pharmaceuticals Presents Late-Breaking Translational Data on Eblasakimab in COPD at the American Thoracic Society International Conference - GlobeNewswire Inc.

ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) Sees Large Growth in Short Interest - Defense World

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.62% - MSN

ASLAN Pharmaceuticals Excels in Eblasakimab TrialsTipRanks.com - TipRanks

ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab ... - Investing.com India

Eblasakimab Shows Promise for AD PatientsTipRanks.com - TipRanks

ASLAN Pharmaceuticals to Present Additional Data From Interim Analysis of TREK-DX Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual KOL Event - GlobeNewswire Inc.

ASLAN Pharmaceuticals to Host KOL Panel Discussion on Treatment Options for Atopic Dermatitis Patients With an Inadequate Response to Dupilumab - GlobeNewswire Inc.

ASLAN Pharmaceuticals (ASLN) Scheduled to Post Earnings on Friday - Defense World

Aslan Pharmaceuticals’ Eblasakimab Shows Promise - TipRanks

ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients - GlobeNewswire Inc.

ASLAN Pharmaceuticals Announces Receipt of Nasdaq Notice - GlobeNewswire Inc.

ASLAN Pharmaceuticals faces Nasdaq delisting over equity deficit - Investing.com

Aslan Pharmaceuticals Launches $12M ADS OfferingTipRanks.com - TipRanks

Are Medical Stocks Lagging ASLAN Pharmaceuticals (ASLN) This Year? - Zacks Investment Research

Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders - GlobeNewswire Inc.

symbol__ Stock Quote Price and Forecast - CNN

Is Aclaris Therapeutics (ACRS) Stock Outpacing Its Medical Peers This Year? - Zacks Investment Research

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.61% - Investing.com India

U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.61% By Investing.com - Investing.com Canada

ASLAN Pharmaceuticals announces $5 million offering - Investing.com

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.12% - Investing.com India

ASLAN Pharmaceuticals extends patent for alopecia drug By Investing.com - Investing.com

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.62% - Investing.com Canada

Valneva (VALN) Up on Antibody Persistence Data on Chikungunya Jab - Yahoo Lifestyle Singapore

Axsome (AXSM) Gains as Alzheimer's Agitation Study Meets Goal - Yahoo Singapore News

Aslan Pharma ADR earnings beat, Revenue Inline in Q2 - Investing.com India

The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal - Yahoo Finance

The Daily Biotech Pulse: Decision Day For Amgen, Zymeworks Sinks On Data, Ortho Clinical Diagnostics IPOiShares ... - Benzinga

ASLAN Pharma (NASDAQ:ASLN) Stock Quotes, Forecast and News Summary - Benzinga

Aslan's Rally Grows After Positive Readout From Eczema Drug StudyASLAN Pharma (NASDAQ:ASLN) - Benzinga

Aslan Dips Into Penny Stock Territory After Company Flunks Late-Stage Cancer StudyASLAN Pharma (NASDAQ - Benzinga

ASLAN Pharmaceuticals (ASLN) Stock Price, News & Analysis - MarketBeat

ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN

Ähnlich wie ASLN